Reversibility and risk allocation.
How much can an institution adjust clinical capability without disproportionate financial, clinical, reputational, or physician-continuity costs—and who bears those costs?
What should an institution measure?
These are exploratory dimensions for institutional review, not a validated scoring instrument.
Adjustment latency
How much notice, authorization, transition time, or replacement capacity is required before changing a commitment?
Financial exposure
What fixed costs, minimum payments, reserves, exit costs, or stranded investments remain during adjustment?
Demand variance
How uncertain is future demand? Are changes isolated or correlated across sites, services, or partners?
Reputational exposure
Would a capacity reduction damage institutional trust, recruitment, or relationships with physicians and communities?
Clinical continuity
What happens to patients, handoffs, response times, institutional context, and responsibility during transition?
Counterparty risk
Which physician, institution, contractor, or intermediary absorbs income, scheduling, opportunity, and transition uncertainty?
Conditional reversibility
What negotiated notice, transition, continuity, or other conditions must be satisfied before capacity changes?
Reversibility and titration are not the same thing
Titration asks what the evidence recommends: INCREASE, HOLD, TAPER, PARK, or GRADUATE. Reversibility asks whether and how a change can actually be carried out under clinical, operational, and contractual constraints.
An assessment that capacity should taper does not create a unilateral right to cancel paid physician hours. Notice periods, commitments, continuity safeguards, and costs must be accounted for.
Who gains flexibility—and who carries the risk?
Reversibility Cost Allocation is a working question about how financial, scheduling, continuity, transition, and opportunity costs are distributed across institutions, physicians, intermediaries, and others. An apparent reduction in institutional risk is not necessarily a reduction in total system risk.
CCI is an independent nonprofit measurement inquiry, neutral among delivery architectures. Clinical Capacity Stewardship Services (CCS) is a separate for-profit effort that may develop particular arrangements. This page does not endorse CCS or describe its proposed commercial terms.
Contribute an institutional example → · Review sources and prior art →